Zim Laboratories Intrinsic Value
Zim Laboratories intrinsic value. Zim Laboratories (ZIMLAB) median intrinsic value is ₹68.55 from 9 valuation models (range ₹41–₹164), vs current price ₹137.10 — -50.0% downside (Trading Above Calculated Value), margin of safety -100.0%. Read ZIMLAB dividend payout details for the complete payout history and dividend yield track record.
ZIMLAB Valuation Methods Summary — DCF, Graham Number & P/E
Zim Laboratories intrinsic value across 9 models vs current price ₹137.10 — upside/downside and value range per method. For current market price and key ratios, visit Zim Laboratories share price screener.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹66.88 | ₹53.50 - ₹80.26 | -51.2% | EPS: ₹3.04, Sector P/E: 22x |
| Book Value Method | asset | ₹109.63 | ₹98.67 - ₹120.59 | -20.0% | Book Value/Share: ₹54.81, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹164.44 | ₹148.00 - ₹180.88 | +19.9% | Revenue/Share: ₹82.22, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹96.30 | ₹86.67 - ₹105.93 | -29.8% | EBITDA: ₹52.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹71.99 | ₹57.59 - ₹86.39 | -47.5% | CF Growth: 0.5%, Discount: 15% |
| PEG Ratio Method | growth | ₹41.13 | ₹37.02 - ₹45.24 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹46.97 | ₹42.27 - ₹51.67 | -65.7% | Revenue Growth: 6.0%, Adj P/E: 15.5x |
| ROE Based Valuation | profitability | ₹68.55 | ₹61.70 - ₹75.41 | -50.0% | ROE: 5.4%, P/E Multiple: 10x |
| Graham Defensive Method | conservative | ₹61.23 | ₹55.11 - ₹67.35 | -55.3% | EPS: ₹3.04, BVPS: ₹54.81 |
ZIMLAB Intrinsic Value vs Market Price — All Valuation Models
Zim Laboratories fair value range ₹41–₹164 vs current market price ₹137.10 across 9 valuation models. Compare with Zim Laboratories valuation methods to assess whether the stock is under or overvalued.
ZIMLAB Intrinsic Value Analysis — Undervalued or Overvalued?
Zim Laboratories median intrinsic value ₹68.55, current price ₹137.10 — Trading Above Calculated Value by 50.0%, margin of safety -100.0%.
What is the intrinsic value of ZIMLAB?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Zim Laboratories (ZIMLAB) is ₹68.55 (median value). With the current market price of ₹137.10, this represents a -50.0% variance from our estimated fair value.
The valuation range spans from ₹41.13 to ₹164.44, indicating ₹41.13 - ₹164.44.
Is ZIMLAB undervalued or overvalued?
Based on our multi-method analysis, Zim Laboratories (ZIMLAB) appears to be trading above calculated value by approximately 50.0%.
ZIMLAB Financial Health — Key Ratios vs Industry Benchmarks
Zim Laboratories financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 5.21 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 5.4% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 7.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.82x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
ZIMLAB Cash Flow Quality — Operating & Free Cash Flow
Zim Laboratories operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2026 | ₹50 Cr | ₹23 Cr | Positive Free Cash Flow | 7/10 |
| March 2025 | ₹41 Cr | ₹21 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹16 Cr | ₹-21 Cr | Positive Operating Cash Flow | 6/10 |
| March 2023 | ₹38 Cr | ₹21 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹49 Cr | ₹42 Cr | Positive Free Cash Flow | 8/10 |